-
Thursday, August 2, 2012 - 3:44pm
Bristol-Myers Executive Charged with Insider Trading
A Bristol-Myers (NYSE: BMY) executive was charged with insider trading Thursday. According to authorities, Robert Ramnarine is charged with buying options in three different companies that Bristol-Myers was trying to acquire. It is illegal to use non-public information for personal gain. On three...
Read More >>


